Europe Osteoarthritis Pain Drugs Market Report 2017

January 2017 | 127 pages | ID: EFA8FD1856CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Osteoarthritis Pain Drugs

Revenue, means the sales value of Osteoarthritis Pain Drugs

This report studies sales (consumption) of Osteoarthritis Pain Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Abbott Laboratories
• Johnson & Johnson
• Novartis
• Pfizer
• AbbVie
• Abiogen Pharma
• Afferent Pharmaceuticals
• Astellas Pharma
• BioDelivery Sciences International
• CrystalGenomics
• Cytori Therapeutics
• Daiichi Sankyo
• Eli Lilly
• Endo Pharmaceuticals Holdings
• Horizon Pharma, iCeutica
• Iroko Pharmaceuticals
• Merck, Nuvo Research
• Regeneron Pharmaceuticals
• Sanofi, SantoSolve
• Techfields Pharma
• Winston Pharmaceuticals
• Yooyoung Pharmaceutical
• Zynerba Pharmaceuticals

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Osteoarthritis Pain Drugs in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Oral
• Injection
• External Use

Split by application, this report focuses on sales, market share and growth rate of Osteoarthritis Pain Drugs in each application, can be divided into

• Hospital
• Clinic

Contents

Europe Osteoarthritis Pain Drugs Market Report 2017

1 OSTEOARTHRITIS PAIN DRUGS OVERVIEW

1.1 Product Overview and Scope of Osteoarthritis Pain Drugs
1.2 Classification of Osteoarthritis Pain Drugs
  1.2.1 Oral
  1.2.2 Injection
  1.2.3 External Use
1.3 Application of Osteoarthritis Pain Drugs
  1.3.1 Hospital
  1.3.2 Clinic
1.4 Osteoarthritis Pain Drugs Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Osteoarthritis Pain Drugs (2011-2021)
  1.5.1 Europe Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Europe Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2021)

2 EUROPE OSTEOARTHRITIS PAIN DRUGS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Osteoarthritis Pain Drugs Market Competition by Manufacturers
  2.1.1 Europe Osteoarthritis Pain Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Osteoarthritis Pain Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Osteoarthritis Pain Drugs (Volume and Value) by Type
  2.2.1 Europe Osteoarthritis Pain Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Osteoarthritis Pain Drugs Revenue and Market Share by Type (2011-2016)
2.3 Europe Osteoarthritis Pain Drugs (Volume and Value) by Countries
  2.3.1 Europe Osteoarthritis Pain Drugs Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Osteoarthritis Pain Drugs Revenue and Market Share by Countries (2011-2016)
2.4 Europe Osteoarthritis Pain Drugs (Volume) by Application

3 GERMANY OSTEOARTHRITIS PAIN DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Osteoarthritis Pain Drugs Sales and Value (2011-2016)
  3.1.1 Germany Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2016)
  3.1.2 Germany Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Osteoarthritis Pain Drugs Sales Price Trend (2011-2016)
3.2 Germany Osteoarthritis Pain Drugs Sales and Market Share by Manufacturers
3.3 Germany Osteoarthritis Pain Drugs Sales and Market Share by Type
3.4 Germany Osteoarthritis Pain Drugs Sales and Market Share by Application

4 FRANCE OSTEOARTHRITIS PAIN DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 France Osteoarthritis Pain Drugs Sales and Value (2011-2016)
  4.1.1 France Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2016)
  4.1.2 France Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2016)
  4.1.4 France Osteoarthritis Pain Drugs Sales Price Trend (2011-2016)
4.2 France Osteoarthritis Pain Drugs Sales and Market Share by Manufacturers
4.3 France Osteoarthritis Pain Drugs Sales and Market Share by Type
4.4 France Osteoarthritis Pain Drugs Sales and Market Share by Application

5 UK OSTEOARTHRITIS PAIN DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Osteoarthritis Pain Drugs Sales and Value (2011-2016)
  5.1.1 UK Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2016)
  5.1.2 UK Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2016)
  5.1.5 UK Osteoarthritis Pain Drugs Sales Price Trend (2011-2016)
5.2 UK Osteoarthritis Pain Drugs Sales and Market Share by Manufacturers
5.3 UK Osteoarthritis Pain Drugs Sales and Market Share by Type
5.4 UK Osteoarthritis Pain Drugs Sales and Market Share by Application

6 RUSSIA OSTEOARTHRITIS PAIN DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Osteoarthritis Pain Drugs Sales and Value (2011-2016)
  6.1.1 Russia Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Russia Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Osteoarthritis Pain Drugs Sales Price Trend (2011-2016)
6.2 Russia Osteoarthritis Pain Drugs Sales and Market Share by Manufacturers
6.3 Russia Osteoarthritis Pain Drugs Sales and Market Share by Type
6.4 Russia Osteoarthritis Pain Drugs Sales and Market Share by Application

7 ITALY OSTEOARTHRITIS PAIN DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Osteoarthritis Pain Drugs Sales and Value (2011-2016)
  7.1.1 Italy Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2016)
  7.1.2 Italy Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Osteoarthritis Pain Drugs Sales Price Trend (2011-2016)
7.2 Italy Osteoarthritis Pain Drugs Sales and Market Share by Manufacturers
7.3 Italy Osteoarthritis Pain Drugs Sales and Market Share by Type
7.4 Italy Osteoarthritis Pain Drugs Sales and Market Share by Application

8 SPAIN OSTEOARTHRITIS PAIN DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Osteoarthritis Pain Drugs Sales and Value (2011-2016)
  8.1.1 Spain Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2016)
  8.1.2 Spain Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Osteoarthritis Pain Drugs Sales Price Trend (2011-2016)
8.2 Spain Osteoarthritis Pain Drugs Sales and Market Share by Manufacturers
8.3 Spain Osteoarthritis Pain Drugs Sales and Market Share by Type
8.4 Spain Osteoarthritis Pain Drugs Sales and Market Share by Application

9 BENELUX OSTEOARTHRITIS PAIN DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Osteoarthritis Pain Drugs Sales and Value (2011-2016)
  9.1.1 Benelux Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Osteoarthritis Pain Drugs Sales Price Trend (2011-2016)
9.2 Benelux Osteoarthritis Pain Drugs Sales and Market Share by Manufacturers
9.3 Benelux Osteoarthritis Pain Drugs Sales and Market Share by Type
9.4 Benelux Osteoarthritis Pain Drugs Sales and Market Share by Application

10 EUROPE OSTEOARTHRITIS PAIN DRUGS MANUFACTURERS ANALYSIS

10.1 Abbott Laboratories
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
    10.1.2.1 Oral
    10.1.2.2 Injection
  10.1.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Johnson & Johnson
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
    10.2.2.1 Oral
    10.2.2.2 Injection
  10.2.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Novartis
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
    10.3.2.1 Oral
    10.3.2.2 Injection
  10.3.3 Novartis Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Pfizer
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
    10.4.2.1 Oral
    10.4.2.2 Injection
  10.4.3 Pfizer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 AbbVie
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
    10.5.2.1 Oral
    10.5.2.2 Injection
  10.5.3 AbbVie Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Abiogen Pharma
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
    10.6.2.1 Oral
    10.6.2.2 Injection
  10.6.3 Abiogen Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Afferent Pharmaceuticals
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
    10.7.2.1 Oral
    10.7.2.2 Injection
  10.7.3 Afferent Pharmaceuticals Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Astellas Pharma
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
    10.8.2.1 Oral
    10.8.2.2 Injection
  10.8.3 Astellas Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 BioDelivery Sciences International
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
    10.9.2.1 Oral
    10.9.2.2 Injection
  10.9.3 BioDelivery Sciences International Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 CrystalGenomics
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Osteoarthritis Pain Drugs Product Type, Application and Specification
    10.10.2.1 Oral
    10.10.2.2 Injection
  10.10.3 CrystalGenomics Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Cytori Therapeutics
10.12 Daiichi Sankyo
10.13 Eli Lilly
10.14 Endo Pharmaceuticals Holdings
10.15 Horizon Pharma, iCeutica
10.16 Iroko Pharmaceuticals
10.17 Merck, Nuvo Research
10.18 Regeneron Pharmaceuticals
10.19 Sanofi, SantoSolve
10.20 Techfields Pharma
10.21 Winston Pharmaceuticals
10.22 Yooyoung Pharmaceutical
10.23 Zynerba Pharmaceuticals

11 OSTEOARTHRITIS PAIN DRUGS MANUFACTURING COST ANALYSIS

11.1 Osteoarthritis Pain Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Osteoarthritis Pain Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Osteoarthritis Pain Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Osteoarthritis Pain Drugs Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE OSTEOARTHRITIS PAIN DRUGS MARKET FORECAST (2016-2021)

14.1 Germany Osteoarthritis Pain Drugs Sales Forecast (2016-2021)
14.2 France Osteoarthritis Pain Drugs Sales Forecast (2016-2021)
14.3 UK Osteoarthritis Pain Drugs Sales Forecast (2016-2021)
14.4 Russia Osteoarthritis Pain Drugs Sales Forecast (2016-2021)
14.5 Italy Osteoarthritis Pain Drugs Sales Forecast (2016-2021)
14.6 Spain Osteoarthritis Pain Drugs Sales Forecast (2016-2021)
14.7 Benelux Osteoarthritis Pain Drugs Sales Forecast (2016-2021)
14.8 Europe Osteoarthritis Pain Drugs Sales Forecast by Type (2016-2021)
14.9 Europe Osteoarthritis Pain Drugs Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Osteoarthritis Pain Drugs
Table Classification of Osteoarthritis Pain Drugs
Figure Europe Sales Market Share of Osteoarthritis Pain Drugs by Type in 2015
Figure Oral Picture
Figure Injection Picture
Figure External Use Picture
Table Application of Osteoarthritis Pain Drugs
Figure Europe Sales Market Share of Osteoarthritis Pain Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure Germany Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2021)
Figure France Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2021)
Figure UK Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2021)
Figure Benelux Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2021)
Figure Europe Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2021)
Table Europe Osteoarthritis Pain Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Osteoarthritis Pain Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Osteoarthritis Pain Drugs Sales Share by Manufacturers
Figure 2016 Osteoarthritis Pain Drugs Sales Share by Manufacturers
Table Europe Osteoarthritis Pain Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Osteoarthritis Pain Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Osteoarthritis Pain Drugs Revenue Share by Manufacturers
Table 2016 Europe Osteoarthritis Pain Drugs Revenue Share by Manufacturers
Table Europe Osteoarthritis Pain Drugs Sales and Market Share by Type (2011-2016)
Table Europe Osteoarthritis Pain Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Osteoarthritis Pain Drugs by Type (2011-2016)
Figure Europe Osteoarthritis Pain Drugs Sales Growth Rate by Type (2011-2016)
Table Europe Osteoarthritis Pain Drugs Revenue and Market Share by Type (2011-2016)
Table Europe Osteoarthritis Pain Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Osteoarthritis Pain Drugs by Type (2011-2016)
Figure Europe Osteoarthritis Pain Drugs Revenue Growth Rate by Type (2011-2016)
Table Europe Osteoarthritis Pain Drugs Sales and Market Share by Countries (2011-2016)
Table Europe Osteoarthritis Pain Drugs Sales Share by Countries (2011-2016)
Figure Sales Market Share of Osteoarthritis Pain Drugs by Countries (2011-2016)
Table Europe Osteoarthritis Pain Drugs Revenue and Market Share by Countries (2011-2016)
Table Europe Osteoarthritis Pain Drugs Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Osteoarthritis Pain Drugs by Countries (2011-2016)
Table Europe Osteoarthritis Pain Drugs Sales and Market Share by Application (2011-2016)
Table Europe Osteoarthritis Pain Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Osteoarthritis Pain Drugs by Application (2011-2016)
Figure Germany Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2016)
Figure Germany Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2016)
Figure Germany Osteoarthritis Pain Drugs Sales Price Trend (2011-2016)
Table Germany Osteoarthritis Pain Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Osteoarthritis Pain Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Osteoarthritis Pain Drugs Sales by Type (2015 and 2016)
Table Germany Osteoarthritis Pain Drugs Market Share by Type (2015 and 2016)
Table Germany Osteoarthritis Pain Drugs Sales by Application (2015 and 2016)
Table Germany Osteoarthritis Pain Drugs Market Share by Application (2015 and 2016)
Figure France Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2016)
Figure France Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2016)
Figure France Osteoarthritis Pain Drugs Sales Price Trend (2011-2016)
Table France Osteoarthritis Pain Drugs Sales by Manufacturers (2015 and 2016)
Table France Osteoarthritis Pain Drugs Market Share by Manufacturers (2015 and 2016)
Table France Osteoarthritis Pain Drugs Sales by Type (2015 and 2016)
Table France Osteoarthritis Pain Drugs Market Share by Type (2015 and 2016)
Table France Osteoarthritis Pain Drugs Sales by Application (2015 and 2016)
Table France Osteoarthritis Pain Drugs Market Share by Application (2015 and 2016)
Figure UK Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2016)
Figure UK Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2016)
Figure UK Osteoarthritis Pain Drugs Sales Price Trend (2011-2016)
Table UK Osteoarthritis Pain Drugs Sales by Manufacturers (2015 and 2016)
Table UK Osteoarthritis Pain Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Osteoarthritis Pain Drugs Sales by Type (2015 and 2016)
Table UK Osteoarthritis Pain Drugs Market Share by Type (2015 and 2016)
Table UK Osteoarthritis Pain Drugs Sales by Application (2015 and 2016)
Table UK Osteoarthritis Pain Drugs Market Share by Application (2015 and 2016)
Figure Russia Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2016)
Figure Russia Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2016)
Figure Russia Osteoarthritis Pain Drugs Sales Price Trend (2011-2016)
Table Russia Osteoarthritis Pain Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Osteoarthritis Pain Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Osteoarthritis Pain Drugs Sales by Type (2015 and 2016)
Table Russia Osteoarthritis Pain Drugs Market Share by Type (2015 and 2016)
Table Russia Osteoarthritis Pain Drugs Sales by Application (2015 and 2016)
Table Russia Osteoarthritis Pain Drugs Market Share by Application (2015 and 2016)
Figure Italy Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2016)
Figure Italy Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2016)
Figure Italy Osteoarthritis Pain Drugs Sales Price Trend (2011-2016)
Table Italy Osteoarthritis Pain Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Osteoarthritis Pain Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Osteoarthritis Pain Drugs Sales by Type (2015 and 2016)
Table Italy Osteoarthritis Pain Drugs Market Share by Type (2015 and 2016)
Table Italy Osteoarthritis Pain Drugs Sales by Application (2015 and 2016)
Table Italy Osteoarthritis Pain Drugs Market Share by Application (2015 and 2016)
Figure Spain Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2016)
Figure Spain Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2016)
Figure Spain Osteoarthritis Pain Drugs Sales Price Trend (2011-2016)
Table Spain Osteoarthritis Pain Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Osteoarthritis Pain Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Osteoarthritis Pain Drugs Sales by Type (2015 and 2016)
Table Spain Osteoarthritis Pain Drugs Market Share by Type (2015 and 2016)
Table Spain Osteoarthritis Pain Drugs Sales by Application (2015 and 2016)
Table Spain Osteoarthritis Pain Drugs Market Share by Application (2015 and 2016)
Figure Benelux Osteoarthritis Pain Drugs Sales and Growth Rate (2011-2016)
Figure Benelux Osteoarthritis Pain Drugs Revenue and Growth Rate (2011-2016)
Figure Benelux Osteoarthritis Pain Drugs Sales Price Trend (2011-2016)
Table Benelux Osteoarthritis Pain Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Osteoarthritis Pain Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Osteoarthritis Pain Drugs Sales by Type (2015 and 2016)
Table Benelux Osteoarthritis Pain Drugs Market Share by Type (2015 and 2016)
Table Benelux Osteoarthritis Pain Drugs Sales by Application (2015 and 2016)
Table Benelux Osteoarthritis Pain Drugs Market Share by Application (2015 and 2016)
Table Osteoarthritis Pain Drugs Basic Information List
Table Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table Abiogen Pharma Basic Information List
Table Abiogen Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abiogen Pharma Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table Afferent Pharmaceuticals Basic Information List
Table Afferent Pharmaceuticals Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Afferent Pharmaceuticals Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astellas Pharma Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table BioDelivery Sciences International Basic Information List
Table BioDelivery Sciences International Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioDelivery Sciences International Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table CrystalGenomics Basic Information List
Table CrystalGenomics Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table CrystalGenomics Osteoarthritis Pain Drugs Sales Market Share (2011-2016)
Table Cytori Therapeutics Basic Information List
Table Daiichi Sankyo Basic Information List
Table Eli Lilly Basic Information List
Table Endo Pharmaceuticals Holdings Basic Information List
Table Horizon Pharma, iCeutica Basic Information List
Table Iroko Pharmaceuticals Basic Information List
Table Merck, Nuvo Research Basic Information List
Table Regeneron Pharmaceuticals Basic Information List
Table Sanofi, SantoSolve Basic Information List
Table Techfields Pharma Basic Information List
Table Winston Pharmaceuticals Basic Information List
Table Yooyoung Pharmaceutical Basic Information List
Table Zynerba Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Osteoarthritis Pain Drugs
Figure Manufacturing Process Analysis of Osteoarthritis Pain Drugs
Figure Osteoarthritis Pain Drugs Industrial Chain Analysis
Table Raw Materials Sources of Osteoarthritis Pain Drugs Major Manufacturers in 2015
Table Major Buyers of Osteoarthritis Pain Drugs
Table Distributors/Traders List
Figure Germany Osteoarthritis Pain Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Germany Osteoarthritis Pain Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure France Osteoarthritis Pain Drugs Sales and Growth Rate Forecast (2016-2021)
Figure France Osteoarthritis Pain Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure UK Osteoarthritis Pain Drugs Sales and Growth Rate Forecast (2016-2021)
Figure UK Osteoarthritis Pain Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Osteoarthritis Pain Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Russia Osteoarthritis Pain Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Osteoarthritis Pain Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Italy Osteoarthritis Pain Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Osteoarthritis Pain Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Spain Osteoarthritis Pain Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Osteoarthritis Pain Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Osteoarthritis Pain Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Europe Osteoarthritis Pain Drugs Sales Forecast by Type (2016-2021)
Table Europe Osteoarthritis Pain Drugs Sales Forecast by Application (2016-2021)